This is Derek Miller, Speaking on Business. BioMérieux is a global leader in in-vitro diagnostics, headquartered in Salt Lake City, where it continues to advance patient care and set global standards in diagnostics. Meghan Kuehn, who leads operations in Salt Lake City, joins us for more.
Meghan Kuehn:
Here in Utah, bioMérieux’s teams are leading the way in advancing innovation and public health across the state, across the nation, and around the world.
BioMérieux’s products are used in more than 160 countries to identify infectious disease, and detect contamination in food, pharmaceutical and cosmetic products. We’re proud to call Salt Lake City our North American Headquarters, where thirty-six hundred team members across six facilities bring their talent to work every day.
R&D, manufacturing, and support teams work together to develop and make diagnostic solutions that identify the source of infectious disease, providing valuable information to health care professionals treating patients. As Utah’s second-largest life-science employer, we collaborate with partners across the state and beyond to address urgent public-health challenges, combat antimicrobial resistance, and support early sepsis detection.
Our work means that test results reach clinicians quickly and clearly, care becomes more precise, and patients and communities around the world are healthier.
Derek Miller:
BioMérieux continues to show that innovation in Utah strengthens public health close to home and around the world. Their diagnostic solutions help healthcare professionals make faster, more informed decisions that save lives every day. Visit BioMérieux.com. I’m Derek Miller, with the Salt Lake Chamber, Speaking on Business.
